| Immune phenotyping of diverse syngeneic murine brain tumors identifies immunologically distinct types JK Khalsa, C Nina, JW Keegan, A Chaudry, J Driver, WL Bi, J Lederer, ... Nature Communications 11 (3912), 2020 | 99 | 2020 |
| Salmonella Engages Host MicroRNAs To Modulate SUMOylation: a New Arsenal for Intracellular Survival S Verma, G Mohapatra, SM Ahmad, S Rana, S Jain, JK Khalsa, ... Molecular and cellular biology 35 (17), 2932-2946, 2015 | 60 | 2015 |
| Mesenchymal stem cell immunomodulation: In pursuit of controlling COVID-19 related cytokine storm N Song, H Wakimoto, F Rossignoli, D Bhere, R Ciccocioppo, KS Chen, ... Stem Cells 39 (6), 707-722, 2021 | 55 | 2021 |
| Tumor interferon signaling is regulated by a lncRNA INCR1 transcribed from the PD-L1 locus M Mineo, SM Lyons, M Zdioruk, N von Spreckelsen, R Ferrer-Luna, H Ito, ... Molecular cell 78 (6), 1207-1223. e8, 2020 | 53 | 2020 |
| Tumor resection recruits effector T cells and boosts therapeutic efficacy of encapsulated stem cells expressing IFNβ in glioblastomas SH Choi, DW Stuckey, S Pignatta, C Reinshagen, JK Khalsa, ... Clinical Cancer Research 23 (22), 7047-7058, 2017 | 44* | 2017 |
| Activation of the MAPK pathway mediates resistance to PI3K inhibitors in chronic lymphocytic leukemia (cll) I Murali, S Kasar, A Naeem, S Tyekucheva, JK Khalsa, EM Thrash, ... Blood, 2021 | 40 | 2021 |
| Modulation of naive CD8 T cell response features by ligand density, affinity, and continued signaling via internalized TCRs R Balyan, R Gund, C Ebenezer, JK Khalsa, DA Verghese, ... The Journal of Immunology 198 (5), 1823-1837, 2017 | 30 | 2017 |
| Functionally significant metabolic differences between B and T lymphocyte lineages JK Khalsa, AS Chawla, SB Prabhu, M Vats, A Dhar, G Dev, N Das, ... Immunology 158 (2), 104-120, 2019 | 26 | 2019 |
| A role for apoptosis-inducing factor in T cell development H Banerjee, A Das, S Srivastava, HR Mattoo, K Thyagarajan, JK Khalsa, ... Journal of Experimental Medicine 209 (9), 1641-1653, 2012 | 17 | 2012 |
| Amyloid form of ovalbumin evokes native antigen-specific immune response in the host S Tufail, M Owais, S Kazmi, R Balyan, JK Khalsa, SM Faisal, ... Journal of Biological Chemistry 290 (7), 4131-4148, 2015 | 16 | 2015 |
| A role for cell‐autocrine interleukin‐2 in regulatory T‐cell homeostasis AS Chawla, JK Khalsa, A Dhar, S Gupta, D Umar, GA Arimbasseri, V Bal, ... Immunology 160 (3), 295-309, 2020 | 14 | 2020 |
| Role of apoptosis-inducing factor (Aif) in the T cell lineage SB Prabhu, JK Khalsa, H Banerjee, A Das, S Srivastava, HR Mattoo, ... Indian Journal of Medical Research 138 (5), 577-590, 2013 | 14 | 2013 |
| Target receptor identification and subsequent treatment of resected brain tumors with encapsulated and engineered allogeneic stem cells D Bhere, SH Choi, P van de Donk, D Hope, K Gortzak, A Kunnummal, ... Nature communications 13 (1), 2810, 2022 | 12 | 2022 |
| Immune profiling of syngeneic murine and patient GBMs for effective translation of immunotherapies JK Khalsa, K Shah Cells 10 (3), 491, 2021 | 8 | 2021 |
| Genetic events associated with venetoclax resistance in CLL identified by whole-exome sequencing of patient samples JK Khalsa, J Cha, F Utro, A Naeem, I Murali, Y Kuang, K Vasquez, L Li, ... Blood 142 (5), 421-433, 2023 | 6 | 2023 |
| Potential Drivers of Acquired Resistance to Idelalisib in CLL Patients S Yadav, J Khalsa, I Murali, RR Furman, NE Kay, E Braggio, JR Brown Blood 140 (Supplement 1), 12373-12374, 2022 | 1 | 2022 |
| Circulating Th17 T cells at treatment onset predict autoimmune toxicity of PI3Kδ inhibitors D Gadi, SP Martindale, PY Chiu, J Khalsa, PH Chen, SM Fernandes, ... Blood Cancer Journal 13 (1), 22, 2023 | | 2023 |
| Mechanisms of primary and acquired resistance to venetoclax in chronic lymphocytic leukemia (CLL) I Murali, J Cha, I Leshchiner, Y Kuang, K Vasquez, J Khalsa, ... Cancer Research 81 (13_Supplement), 1097-1097, 2021 | | 2021 |
| Abstract LB-354: Immune phenotyping of diverse syngeneic brain tumors identifies critical tumor micro-environmental differences JK Khalsa, JW Keegan, N Cheng, J Driver, A Chaudry, WL Bi, JA Lederer, ... Cancer Research 80 (16_Supplement), LB-354-LB-354, 2020 | | 2020 |
| Immune phenotyping of diverse syngeneic brain tumors identifies critical tumor micro-environmental differences JK Khalsa, JW Keegan, N Cheng, J Driver, A Chaudry, WL Bi, JA Lederer, ... CANCER RESEARCH 80 (16), 2020 | | 2020 |
